MicroRNA-206 is differentially expressed in Brca1-deficient mice and regulates epithelial and stromal cell

A Wronski1, G K Sandhu1, M J G Milevskiy1

  • 1School of Chemistry and Molecular Biosciences, University of Queensland, St Lucia, Queensland, Australia.

Oncogenesis
|April 5, 2016
PubMed

Insights

Loss of Brca1 impacts mammary gland development. MicroRNAs (miRNAs), including miR-206, may mediate these effects and play a role in tissue remodeling, but not tumor formation.

Area of Science:

  • Molecular Biology
  • Genetics
  • Developmental Biology

Background:

  • Brca1 (Breast cancer gene 1) is crucial for mammary gland development and preventing tumors.
  • Dysregulation of microRNAs (miRNAs) is implicated in various cancers, including breast cancer.

Purpose of the Study:

  • To investigate the role of miRNAs in Brca1-deficient mouse mammary glands.
  • To identify specific miRNAs that are differentially expressed upon Brca1 loss.
  • To determine the functional significance of identified miRNAs, particularly miR-206, in mammary gland development and function.

Main Methods:

  • Differential miRNA expression analysis in MMTV-Cre Brca1(Co/Co) mice mammary glands and Brca1-depleted cell lines.
  • In vitro functional assays to assess miRNA regulation of mammary epithelial cell function.
  • Generation and analysis of MMTV-miR-206 transgenic mice.

Main Results:

  • Several miRNAs were found to be differentially expressed in Brca1-deficient mammary tissue and cells.
  • miR-206 was identified as a regulator of mammary epithelial cell function in vitro.
  • MMTV-miR-206 transgenic mice showed no defects in lactation or tumor development, but exhibited altered mammary tissue remodeling in mature mice, potentially involving Igf-1 and Sfrp1.

Conclusions:

  • miRNAs have the potential to mediate the cellular consequences of Brca1 loss.
  • miR-206 plays a role in mammary tissue remodeling in mature mice, independent of Brca1-driven tumor suppression or lactational development.